CVSG.F Stock Overview
CVS Group plc, together with its subsidiaries, engages in veterinary, pet crematoria, online pharmacy, and retail businesses.
| Snowflake Score | |
|---|---|
| Valuation | 4/6 |
| Future Growth | 1/6 |
| Past Performance | 4/6 |
| Financial Health | 4/6 |
| Dividends | 3/6 |
CVS Group plc Competitors
Price History & Performance
| Historical stock prices | |
|---|---|
| Current Share Price | UK£19.94 |
| 52 Week High | UK£19.94 |
| 52 Week Low | UK£18.99 |
| Beta | 0.95 |
| 1 Month Change | 0% |
| 3 Month Change | n/a |
| 1 Year Change | n/a |
| 3 Year Change | n/a |
| 5 Year Change | 160.65% |
| Change since IPO | 45.02% |
Recent News & Updates
Recent updates
Shareholder Returns
| CVSG.F | US Healthcare | US Market | |
|---|---|---|---|
| 7D | 0% | -1.3% | -3.5% |
| 1Y | n/a | -2.9% | 20.2% |
Return vs Industry: Insufficient data to determine how CVSG.F performed against the US Healthcare industry.
Return vs Market: Insufficient data to determine how CVSG.F performed against the US Market.
Price Volatility
| CVSG.F volatility | |
|---|---|
| CVSG.F Average Weekly Movement | n/a |
| Healthcare Industry Average Movement | 7.2% |
| Market Average Movement | 6.0% |
| 10% most volatile stocks in US Market | 16.5% |
| 10% least volatile stocks in US Market | 3.0% |
Stable Share Price: CVSG.F has not had significant price volatility in the past 3 months.
Volatility Over Time: Insufficient data to determine CVSG.F's volatility change over the past year.
About the Company
| Founded | Employees | CEO | Website |
|---|---|---|---|
| 1999 | 9,100 | Richard William Fairman | www.cvsukltd.co.uk |
CVS Group plc, together with its subsidiaries, engages in veterinary, pet crematoria, online pharmacy, and retail businesses. The company operates through four segments: Veterinary Practices, Laboratories, Crematoria, and Online Retail Business. It operates in animal veterinary practices and complementary veterinary diagnostic businesses.
CVS Group plc Fundamentals Summary
| CVSG.F fundamental statistics | |
|---|---|
| Market cap | US$839.76m |
| Earnings (TTM) | US$44.00m |
| Revenue (TTM) | US$797.86m |
19.1x
P/E Ratio1.1x
P/S RatioIs CVSG.F overvalued?
See Fair Value and valuation analysisEarnings & Revenue
| CVSG.F income statement (TTM) | |
|---|---|
| Revenue | UK£641.90m |
| Cost of Revenue | UK£365.20m |
| Gross Profit | UK£276.70m |
| Other Expenses | UK£241.30m |
| Earnings | UK£35.40m |
Last Reported Earnings
Dec 31, 2023
Next Earnings Date
Sep 26, 2024
| Earnings per share (EPS) | 0.49 |
| Gross Margin | 43.11% |
| Net Profit Margin | 5.51% |
| Debt/Equity Ratio | 59.6% |
How did CVSG.F perform over the long term?
See historical performance and comparison